• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Best Managed Accounts
  • Forex Robots
  • Forex Brokers
  • Forex Signals
  • Social Trading Platforms
  • Community Reviews

  • Robots
  • Start Guide
  • Glossary
  • Basics
    • Currency Pairs
    • Charts
    • Candlesticks
    • Trading Tips
  • Strategies
    • Technical Analysis
    • Fundamental Analysis
    • Day Trading
    • Scalping
    • Swing Trading
    • Trend Following
  • News
  • Reviews
    • Forex Robots
    • Forex Brokers
  • Mustreads
  • Crypto Trading

Kodiak Sciences Ends Development of Lead Investigational Medicine

July 25, 2023 by Forex Winner Leave a Comment

Shares of Kodiak Sciences plunged by over 50% in premarket trading on Monday as the biopharmaceutical company announced the termination of its lead investigational medicine, tarcocimab tedromer. This decision comes after the failure of two Phase 3 studies focusing on the treatment of diabetic macular edema.

Disappointing Results in Phase 3 Studies

Kodiak Sciences, headquartered in Palo Alto, California, revealed that both studies failed to meet their primary efficacy endpoints, which aimed to demonstrate non-inferior visual acuity gains compared to aflibercept. The company attributes these failures to an unexpected rise in cataracts observed in the tarcocimab study groups over time.

Best Forex Robots ›

Compare leading trading systems on the market

The Impact on Regulatory and Clinical Development Strategy

While a separate Phase 3 study concerning wet age-related macular degeneration did achieve the primary endpoint of non-inferior visual acuity gains when compared with aflibercept, Kodiak emphasizes that successful outcomes in the diabetic macular edema studies were crucial for the regulatory and clinical development strategy of tarcocimab.

Financial Stability Amidst New Plans

Kodiak reassures stakeholders that it is financially stable as it adjusts its near-term business plan. The company reported approximately $379 million in cash and equivalents as of June 30.

As a result of this announcement, Kodiak shares experienced a significant decline, falling nearly 56% from $7.29 to $3.24 in premarket trading on the same day.

For more information, please visit source

Best Forex Robots ›

Compare leading trading systems on the market

Filed Under: Forex News Tagged With: Cataracts, Clinical Development, Diabetic Macular Edema, Financial Stability, Investigational Medicine, Kodiak Sciences, Phase 3 Studies, Regulatory Strategy, Visual Acuity

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Best Forex Robots

  1. Techberry 8.7
  2. Happy Forex 8.0
  3. Forex Fury 7.7
  4. Promax Gold EA 6.8
  5. Gump EA 6.4

Best Forex Brokers

  1. Techberry 8.7
  2. XM 8.2
  3. eToro 8.1
  4. Pepperstone 8.1
  5. IG 8.0

Latest News

Man charged in New York with 3-week kidnapping to try to steal Bitcoin

May 30, 2025

Goldman Sachs Expert Predicts Significant Gold Price Surge by 2026

May 29, 2025

Second suspect in New York bitcoin kidnapping surrenders to police

May 28, 2025

Footer

Forex Broker Reviews

tier1fx

Tier1fx Review

February 18, 2020 By Forex Winner

FXCM

FXCM Review

November 13, 2019 By Forex Winner

eToro

eToro Review

April 23, 2019 By Forex Winner

Forex Robot Reviews

Earn2Trade Review

August 20, 2023 By Shandor Brenner

FundedNext Review

August 16, 2023 By Shandor Brenner

Topstep Forex Review

August 14, 2023 By Shandor Brenner

EMAIL NEWSLETTER

Sign up to receive exclusive forex trading guides and insights from our team of experts!

Copyright © 2025 · Forex Traders Guide · About Us · Contact Us
Privacy Policy · Risk Disclosure